Primary closure of the midline abdominal wall defect during laparoscopic ventral hernia repair: analysis of risk factors for failure and outcomes at 5 years follow-up

Gómez-Menchero, Julio; Balla, Andrea; Carazo, Ana F.; Morales‐Conde, Salvador

doi:10.1007/s00464-022-09374-9

Cited by 9 publications

(3 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…8 Many studies have left the defect open 12,16,18,19,22 with acceptable recurrence rates ranging from 1.7% 12 to 6.5%, 22 and even in the MORPHEUS trial there was a 14% of cases without fascial closure. 8,10 However, trends in abdominal wall surgery have evolved towards a complete anatomical restoration with mesh reinforcement, 35 which results in a reduced rate of seroma and recurrence. 36 Another limitation of the study remains in its retrospective design, where we were limited to the analysis of the available data.…”

Section: Discussionmentioning

confidence: 99%

Parietex™ Composite Ventral Patch for primary and incisional hernia repair

Barranquero

Villalobos

González

et al. 2023

ANZ Journal of Surgery

View full text Add to dashboard Cite

Backgrounds Ventral hernia repair with a preformed device is a frequent intervention, but few reports exist with Parietex™ Composite Ventral Patch. The aim was to evaluate the results of this mesh with the open intraperitoneal onlay mesh (open IPOM) technique. Methods Observational retrospective single institution study of all consecutive patients intervened for ventral or incisional hernia with a diameter inferior to 4 cm, from January 2013 to June 2020. The surgical repair was performed according to the open IPOM technique with Parietex™ Composite Ventral Patch. Results A total of 146 patients were intervened: 61.6% with umbilical hernias, 8.2% with epigastric hernias, 26.7% with trocar incisional hernias, and 3.4% with other incisional hernias. The global recurrence rate was 7.5% (11/146). Specifically, it was 7.8% in umbilical hernias, 0% in epigastric hernias, 7.7% in trocar incisional hernias and 20% (1/5) in other incisional hernias. The median time for recurrence was 14 months (IQR: 4.4–18.7). The median indirect follow‐up was 36.9 months (IQR: 27.2–49.6), and the median presential follow‐up was 17.4 months (IQR: 6.5–27.3). Conclusion The open IPOM technique with a preformed patch offered satisfactory results for the treatment of ventral and incisional hernias.

show abstract

Section: Discussionmentioning

confidence: 99%

Parietex™ Composite Ventral Patch for primary and incisional hernia repair

Barranquero

Villalobos

González

et al. 2023

ANZ Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…Several studies comparing the sIPOM and IPOM-Plus approaches have also presented combined findings for repairs of incisional and primary AWHs. [16][17][18][19][20] This article focuses on small and medium-sized PMAWHs and compares the outcomes of the sIPOM and IPOM-Plus techniques.…”

Section: Discussionmentioning

confidence: 99%

Küçük ve Orta Büyüklükteki Primer Ortahat Karın Duvarı FıtIklarında sIPOM ve IPOM-Plus Tekniklerinin Sonuçlarının Karşılaştırılması

TAŞDELEN

2023

Journal of Contemporary Medicine

View full text Add to dashboard Cite

Abstract Aims: To compare the results of the standard intraperitoneal onlay mesh (sIPOM) and intraperitoneal onlay mesh-plus (IPOM-Plus) techniques for the repair of small and medium-sized primary midline abdominal wall hernias (PMAWHs). Material and Method: A prospectively documented data of 82 patients who underwent the sIPOM and IPOM-Plus approach between January 2016 and December 2021 was retrospectively evaluated. Forty-one patients with PMAWH repaired with sIPOM (18) and IPOM-Plus (23) were included in the study. Median follow-up for the sIPOM and IPOM-Plus was 73 and 51 months (mean 73.83±7.81vs. 47.43±19.22), respectively. Results: Both groups had no difference in demographics, comorbidities, and smoking habits. The mesh area (MA) and the mesh-to-defect ratio (MDR) were not significant (p=0.083 and p= 0.30, respectively); however, the defect area (DA) was higher in the sIPOM group (p= 0.005). The IPOM-Plus group had a longer operative time and length of hospital stay (LOHS) and higher early postoperative pain than the IPOM group (p = 0.002, p = 0.049 and p

show abstract

“…Use of synthetic or biological mesh, advances in surgical technique, better knowledge of respiratory mechanics, and better perioperative care have decreased this growing issue [ 30 , 31 ]. These important improvements in VH management and treatment, unfortunately, were not enough to definitely resolve the problem of recurrence.…”

Section: Discussionmentioning

confidence: 99%

Is There Indication for the Use of Biological Mesh in Cancer Patients?

Patrone

Leongito²,

Giacomo³

et al. 2022

JCM

View full text Add to dashboard Cite

Up to 28% of all patients who undergo open surgery will develop a ventral hernia (VH) in the post-operative period. VH surgery is a debated topic in the literature, especially in oncological patients due to complex management. We searched in the surgical database of the Hepatobiliary Unit of the National Cancer Institute of Naples “G. Pascale Foundation” for all patients who underwent abdominal surgery for malignancy from January 2010 to December 2018. Our surgical approach and our choice of mesh for VH repair was planned case-by-case. We selected 57 patients that fulfilled our inclusion criteria, and we divided them into two groups: biological versus synthetic prosthesis. Anterior component separation was used in 31 patients (54.4%) vs. bridging procedure in 26 (45.6%). In 41 cases (71.9%), we used a biological mesh while a synthetic one was adopted in the remaining patients. Of our patients, 57% were male (33 male vs. 24 female) with a median age of 65 and a mean BMI of 30.8. We collected ventral hernia defects from 35 cm2 to 600 cm2 (mean 205.2 cm2); 30-day complications were present in 24 patients (42.1%), no 30-day mortality was reported, and 21 patients had a recurrence of pathology during study follow-up. This study confirms VH recurrence risk is not related with the type of mesh but is strongly related with BMI and type of surgery also in oncological patients.

show abstract

Primary closure of the midline abdominal wall defect during laparoscopic ventral hernia repair: analysis of risk factors for failure and outcomes at 5 years follow-up

Cited by 9 publications

References 37 publications

Parietex™ Composite Ventral Patch for primary and incisional hernia repair

Parietex™ Composite Ventral Patch for primary and incisional hernia repair

Küçük ve Orta Büyüklükteki Primer Ortahat Karın Duvarı FıtIklarında sIPOM ve IPOM-Plus Tekniklerinin Sonuçlarının Karşılaştırılması

Is There Indication for the Use of Biological Mesh in Cancer Patients?

Contact Info

Product

Resources

About